Showing results (51-60 of 160) with videos related to
Sort By:
Pageof 16
Mycoses|August 22, 2015
Is the extraction by Whatman FTA filter matrix technology and sequencing of large ribosomal subunit D1-D2 region sufficient for identification of clinical fungi?Nuri Kiraz, Yasemin Oz, Huseyin Aslan, et al.The Journal of Antimicrobial Chemotherapy|November 4, 2022
Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafunginMaiken Cavling Arendrup, Sevtap Arikan-Akdagli, Mariana Castanheira, et al.Mycoses|April 4, 2018
In vitro activities of antifungal drugs against environmental Exophiala isolates and review of the literatureDolunay Gülmez, Özlem Doğan, Barış Boral, et al.Diagnostic Microbiology and Infectious Disease|February 20, 2004
Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patientsJohn F Mohr, Audrey Wanger, John H RexThe Journal of Antimicrobial Chemotherapy|August 6, 2016
Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causalityWilliam Hope, George L Drusano, John H RexJournal De Mycologie Medicale|February 4, 2024
Invasive fungal rhinosinusitis by Fusarium proliferatum/annulatum in a patient with acute myeloid leukemia: A case report and review of the literatureZeynep Cansu Caliskan, Gizem Karahan, Neslihan Koray, et al.Medical Mycology|December 11, 2012
Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samplesIlknur Tosun, Zeynep Akyuz, Nejla Cebeci Guler, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center AnalysisUgur Balaban, Emre Kara, Asli Pinar, et al.Open Forum Infectious Diseases|July 20, 2022
The Value of the Information That Can Be Generated: Optimizing Study Design to Enable the Study of Treatments Addressing an Unmet Need for Rare PathogensAaron Dane, John H Rex, Paul Newell, et al.Archives of Medical Research|October 12, 2005
Invasive candidiasis in immunocompromised hospitalized patientsCharles R Sims, Luis Ostrosky-Zeichner, John H RexPageof 16